🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study will evaluate if a combination of saxagliptin and dapagliflozin added...
Status
Completed
Location
Research Site
Start Date
2014-09-09
Trial ID
NCT02284893
The study titled "Efficacy and Safety of Omarigliptin, A Weekly Dipeptidyl ...
Status
Unknown
Location
BIRDEM General Hospital
Start Date
2024-09
Trial ID
NCT06449235
Three SGLT2i were commercially available in Italy at the time the trial was...
Status
Unknown
Location
Multiple Locations
Start Date
2021-06-30
Trial ID
NCT04796428
Treatments Being Tested
A phase IV, randomized, double-blind, single center pilot study in subjects...
Status
Completed
Location
Department of Endocrinology and Metabolism, University of Pisa
Start Date
2018-07-24
Trial ID
NCT03714594
Treatments Being Tested
The purpose of this study is to learn if BMS-512148 (Dapagliflozin) as part...
Status
Completed
Location
University Of Alabama At Birmingham
Start Date
2012-09
Trial ID
NCT01646320
Treatments Being Tested
The purpose of this study is to evaluate whether the pharmacokinetics (body...
Status
Completed
Location
Icon Clinical Pharmacology
Start Date
2012-08
Trial ID
NCT01662999
Treatments Being Tested
The Investigator hypothesize that Dapagliflozin will improve EPC number and...
Status
Terminated
Location
The GW Medical Faculty Associates
Start Date
2018-10-22
Trial ID
NCT03660683
Treatments Being Tested
This is a 24-week, multicenter, randomized, double-blind, double-dummy, pla...
Status
Terminated
Location
Research Site
Start Date
2019-02-27
Trial ID
NCT03608358
A Study to Assess the Fed-state Bioequivalence of a Triple Fixed-Combinatio...
Status
Completed
Location
Research Site
Start Date
2017-05-29
Trial ID
NCT03169959
Treatments Being Tested
This is a 16-week, single center, randomized, double-blind, active-controll...
Status
Completed
Location
The University of Texas Health Science Center at San Antonio
Start Date
2016-01
Trial ID
NCT02613897
Treatments Being Tested